Skip to main content
. 2020 Apr 14;3(4):e202739. doi: 10.1001/jamanetworkopen.2020.2739

Figure. Part D Cost-Sharing Between Patients, Insurance Plans, Manufacturers, and Medicare for Median-Priced Antiretroviral Therapy (ART) and Preexposure Prophylaxis (PrEP).

Figure.